Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Screaming Eagle de-SPAC transaction with Lionsgate’s studio business
We are advising the placement agents on the de-SPAC transaction and the related PIPE financing
Nextracker spinoff from Flex
We advised Nextracker on its spinoff
Modern Land (China) consent solicitation
The consent solicitation included multiple tranches of outstanding senior notes
Bread Financial Holdings $600 million senior notes offering
We advised Bread Financial on its high-yield debt offering
HighTide Therapeutics HK$194.1 million IPO
We advised HighTide Therapeutics on its IPO and HKEX listing
Auna exchange offer and consent solicitations
We advised the Auna on the transaction
Infracommerce CXaaS R$400 million equity offering
The common shares and warrants are listed on the São Paulo Stock Exchange
Mongolian Mining tap notes issuance
We advised Mongolian Mining on the issuance of additional 12.5% senior notes due 2026
Zhejiang Expressway $860 million rights issue
The H shares are listed on the Hong Kong Stock Exchange
Evergy $1.4 billion convertible notes offering
The 4.5% convertible notes are due 2027